Hostname: page-component-7479d7b7d-pfhbr Total loading time: 0 Render date: 2024-07-12T01:59:17.664Z Has data issue: false hasContentIssue false

2155 – Pilot Supervision Programme (psp) For High Risk Patients In The Community

Published online by Cambridge University Press:  15 April 2020

C. Lee
Affiliation:
Community Psychiatry, Singapore, Singapore
J. Hariram
Affiliation:
Institute of Mental Health, Singapore, Singapore
M.C. Chan
Affiliation:
Institute of Mental Health, Singapore, Singapore
M. Alexander
Affiliation:
Institute of Mental Health, Singapore, Singapore
S.H. Ong
Affiliation:
Institute of Mental Health, Singapore, Singapore

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

The Community Treatment Order (CTO) Programme has been in place in several countries and encompasses the legislative requirement of a group of psychiatric patients to receive psychiatric treatment.

The Institute of Mental Health (IMH),Singapore has implemented a pilot supervision programme (PSP) that contains elements of the CTO programme (but without the requirement for legislative changes).

The objective of PSP is to engage patients with serious mental disorders, such as schizophrenia, delusional disorder, bipolar disorder (as per the Diagnostic and Statistical Manual of Mental Disorders IV criteria) to continue to receive treatment while living in the community, the least restrictive environment.

This paper focuses on the implementation of Phase 1 of PSP. Phase 1 which cover a period of one year focuses on ‘high-risk‘ patients who suffer from a major psychiatric disorder and had 3 and more inpatient admissions over the past 1 year. They are then divided into 3 groups (70 each):

  1. 1) Group 1: Receiving standard community mental health treatment (monthly visit) and service is chargeable.

  2. 2) Group 2: Same as Group 1 but service is pro-bono.

  3. 3) Group 3: Receiving intensive community mental health treatment (weekly visit) and service is pro-bono.

In addition, patients in Group 2 and 3 will also receive incentives such as welfare voucher.

The results of Phase 1 will provide a better understanding of the patient's motivation and/or compliance for treatment and forms the test bed for Phase 2 which will include psychiatric patients with significant Axis II diagnoses.

Type
Abstract
Copyright
Copyright © European Psychiatric Association 2012
Submit a response

Comments

No Comments have been published for this article.